We are so proud to see Dr. Hans Hammers’s clinical trial of RADVAX selected for presentation at ASCO GU 2020. ASCO is the American Society of Clinical Oncology, and ASCO GU focuses on genitourinary cancers.

RADVAX combines SBRT with immunotherapy. This clinical trial showed that high-dose radiation added to immunotherapy can help more patients respond to immunotherapy. Using SBRT to inflame tumors can help the immune system recognize the tumor and therefore increases the response rate to immunotherapy. Higher response rates show that radiation is helping turn some people whose cancer would not respond to immunotherapy (non-responders) into responders.

The encouraging results for kidney cancer patients from this preliminary trial led to the selection of Dr. Hans Hammers and RADVAX for a presentation at ASCO.  

This trial was 100% patient and community funded through the grassroots efforts of Ralph and Brenda Knapp and KidneyCAN.

After impressive response rates, Bristol Myers Squibb has funded this SBRT and immunotherapy combination for continued research, which we hope to see translate quickly to clinical use. Ralph was one of the first patients to receive RADVAX and is pictured here with his wife Brenda and Dr. Hammers. 

Ralph and Brenda Knapp with Dr. Hans Hammers

You can check out Dr. Hammers’s ASCO GU abstract here, but do follow us on Facebook and Twitter to see our live updates of the event this week!

 

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORY BOARD →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter Joslin holding granddaughter...

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

District Days 2021: Speaking with One Voice

District Days 2021: Speaking with One Voice

Our Ask: Fund Kidney Cancer Research We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.For District Days, the kidney cancer community met with members of Congress all over the United States to ask for robust funding of kidney cancer...

FACING KIDNEY CANCER →

DIAGNOSIS →

BUILDING A CARE TEAM →

LEARN ABOUT CLINICAL TRIALS →

LIVING WELL WITH KIDNEY CANCER →

DONATE →

CONTACT →

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter Joslin holding granddaughter...

KCRS →

RESEARCH OPPORTUNITIES →

ADVOCATE WITH KIDNEYCAN →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

District Days 2021: Speaking with One Voice

District Days 2021: Speaking with One Voice

Our Ask: Fund Kidney Cancer Research We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.For District Days, the kidney cancer community met with members of Congress all over the United States to ask for robust funding of kidney cancer...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter Joslin holding granddaughter...